Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment

The possible use of inflammatory parameters as a predictor of coronary artery lesions (CAL) and the effect of intravenous immunoglobulin (IVIG) treatment in 30 Swedish children with acute Kawasaki disease were investigated. All the patients were treated with IVIG (2 g/kg) and seven of them had CAL. Ten febrile children, hospitalized for treatment of severe infection, and 15 healthy children served as controls. The levels of soluble E‐selectin and soluble intercellular adhesion molecule (ICAM)‐1 in the Kawasaki patients were elevated in comparison to healthy, but not in comparison to febrile controls. Paired analysis of our patients before and after IVIG therapy during acute disease revealed lowered levels of C‐reactive protein, interleukin‐6, soluble E‐selectin and soluble ICAM‐1. We found no statistically significant relationships among any of these parameters as a possible predictor of CAL, but three patients with cardiac sequelae demonstrated high values for these inflammatory parameters. These findings may reflect endothelial activation in connection with vasculitis, and the anti‐inflammatory effect of IVIG treatment lowering cytokine levels and subsequently decreasing the expression and shedding of adhesion molecules. In conclusion, we were unable to identify a predictor of CAL in the acute phase. The patients had higher levels of soluble E‐selectin and soluble ICAM‐1 than did afebrile controls, but not febrile controls. The patients’levels of C‐reactive protein, interleukin‐6, soluble E‐selectin and soluble ICAM‐1 were decreased after 1—2 d of IVIG treatment. □Coronary artery lesions, inflammatory parameters, intravenous immunoglobulin, Kawasaki disease, vasculitis

[1]  A. Bisno,et al.  Diagnostic guidelines for Kawasaki disease. , 2001, Circulation.

[2]  Chini,et al.  Characterization of the T‐Cell Receptor V‐β Repertoire in Kawasaki Disease , 1998, Scandinavian journal of immunology.

[3]  S. Shulman,et al.  Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. , 1997, The Journal of pediatrics.

[4]  K. Hirayama,et al.  Circulating soluble selectins in Kawasaki disease , 1997, Clinical and experimental immunology.

[5]  D. Leung,et al.  Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. , 1995, Journal of immunology.

[6]  H. Igarashi,et al.  The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. , 1995, The Journal of infectious diseases.

[7]  A. Fasth,et al.  Kawasaki disease in Sweden: incidence and clinical features , 1995, Acta paediatrica.

[8]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[9]  O. Strannegard,et al.  Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. , 1994, The Journal of infectious diseases.

[10]  E. Giannini,et al.  TCR V beta family repertoire and T cell activation markers in Kawasaki disease. , 1994, Journal of immunology.

[11]  A. Maffey,et al.  Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. , 1994, The Journal of pediatrics.

[12]  M. Drayson,et al.  Circulating soluble adhesion molecules in systemic vasculitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  D. Kim,et al.  Serum soluble E-selectin levels in Kawasaki disease. , 1994, Scandinavian journal of rheumatology.

[14]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[15]  B. Chiang,et al.  Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. , 1992, The Journal of pediatrics.

[16]  A. Yachi,et al.  Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. , 1992, Arthritis and rheumatism.

[17]  H. Yanagawa,et al.  Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. , 1991, Pediatrics.

[18]  D. Leung The Potential Role of Cytokine‐Mediated Vascular Endothelial Activation in the Pathogenesis of Kawasaki Disease , 1991, Acta paediatrica Japonica : Overseas edition.

[19]  S. Shulman,et al.  Nationwide survey of Kawasaki disease and acute rheumatic fever. , 1991, The Journal of pediatrics.

[20]  H. Nakano,et al.  Intravenous gamma-globulin for Kawasaki disease. , 1991, Acta paediatrica Japonica : Overseas edition.

[21]  F. Orson,et al.  Soluble interleukin-2 receptors in children with Kawasaki syndrome. , 1990, Arthritis and rheumatism.

[22]  K. Yabuta,et al.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.

[23]  J. Newburger,et al.  ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASE , 1989, The Lancet.

[24]  H. Kanegane,et al.  The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. , 1989, Clinical and experimental immunology.

[25]  P. Pelkonen,et al.  Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. , 1989, The Journal of laboratory and clinical medicine.

[26]  S. Daniels,et al.  Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. , 1986, Journal of the American College of Cardiology.

[27]  J. Newburger,et al.  The treatment of Kawasaki syndrome with intravenous gamma globulin. , 1986 .

[28]  H. Nakano,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE , 1983, The Lancet.

[29]  H. Yanagawa,et al.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.

[30]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].

[31]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.